RecruitingNCT06860516

HLA Demographics Study in Adults With Type 1 Diabetes

A Non-interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)

Sponsor

GentiBio, Inc

Enrollment

200 participants

Start Date

Jun 6, 2025

Study Type

OBSERVATIONAL

Conditions

Diabetes Mellitus, Type I

Summary

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting HLA (human leukocyte antigen) genetic data from adults recently diagnosed with Type 1 diabetes to better understand the genetic patterns associated with the disease. This information may help improve future research into diabetes prevention and treatment. **You may be eligible if...** - You are aged 18–45 - You have been diagnosed with Type 1 diabetes within the past 2 months, meeting American Diabetes Association criteria (based on blood sugar or HbA1c levels) - You are able to provide your own written informed consent **You may NOT be eligible if...** - You work for or are an immediate family member of an employee of the study sponsor or site staff - You are unwilling or unable to attend the required study visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.